| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.9M | +123.6% |
| R&D Expense | $16.7M | +41.0% |
| SG&A Expense | $11.4M | +28.9% |
| Operating Income | -$22.6M | -30.8% |
| Pre-tax Income | -$21.2M | -36.0% |
| Income Tax | $3K | +100.4% |
| Net Income | -$21.2M | -42.6% |
| EPS (Basic) | -$1.27 | -29.6% |
| EPS (Diluted) | -$1.27 | -29.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.8M | +22.1% |
| Current Assets | $49.9M | +12.7% |
| Total Assets | $50.0M | +12.6% |
| Current Liabilities | $5.9M | +53.5% |
| Total Liabilities | $6.9M | +45.1% |
| Stockholders' Equity | $43.0M | +8.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | -4.4% |
| Investing Cash Flow | -$1.2M | -4558.4% |
| Financing Cash Flow | $20.4M | +27.2% |